Skip to content

A Multicenter Case-control Study of Risk Factors for Premature Ejaculation in China's Shaanxi Province

A Multicenter Case-control Study of Risk Factors for Premature Ejaculation in China's Shaanxi Province

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04235192
Enrollment
1340
Registered
2020-01-21
Start date
2019-07-31
Completion date
2020-10-01
Last updated
2020-01-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Premature Ejaculation

Keywords

risk factor

Brief summary

Through a multicenter case-control study on the risk factors of premature ejaculation in Shaanxi, to find out the related factors of the occurrence and development of premature ejaculation, to provide reference for personalized treatment, in order to improve the quality of sexual life of patients and partners.

Interventions

None listed

Sponsors

First Affiliated Hospital Xi'an Jiaotong University
CollaboratorOTHER
Shaanxi Provincial People's Hospital
CollaboratorOTHER
Xi'an No.3 Hospital
CollaboratorOTHER_GOV
Shaanxi Armed Police Corps Hospital
CollaboratorUNKNOWN
Northwest Women's and Children's Hospital, Xi'an, Shaanxi
CollaboratorOTHER
Xijing Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
MALE
Age
18 Years to 64 Years
Healthy volunteers
Yes

Inclusion criteria

* 1\) case group 1. 18-64 years old, regular sexual life \> 6 months; 2. Self-report of premature ejaculation; 3. Able to complete questionnaires and scale scores independently. 2) control group <!-- --> 1. 18-64 years old, regular sexual life \> 6 months; 2. Both partners are satisfied with their sexual life; 3. Able to complete questionnaires and scale scores independently.

Exclusion criteria

* 1\) case group 1. Those who are unable to have sex due to genital malformation; 2. Patients with serious cardiovascular and cerebrovascular diseases; 3. Severe mental disorders (history of epilepsy, mania, etc.); 4. Have a history of brain trauma; 5. People with a long history of substance abuse. 2) control group <!-- --> 1. Patients with a history of mental illness; 2. Oral selective serotonin (5-ht) reuptake inhibitors, tricyclic antidepressants, triazolidine antidepressants, tramadol and sedatives

Design outcomes

Primary

MeasureTime frameDescription
IELTWithin 6 monthsIntra-vaginal Ejaculation Latency Time

Countries

China

Contacts

Primary ContactJianlin Yuan, doctor
jianliny@fmmu.edu.cn+86-136-0912-3155

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026